Condition

Stage III Prostate Cancer AJCC v7

ClinicalTrials.gov condition label

Clinical trials8

Recruiting2

Common interventions21

Lead sponsors shown6

Clinical trials

8 shown

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate CancerNCT04775355 · 2021-04-14

Fatigue Interventions in Cancer (Exercise Intervention)NCT03421782 · 2018-02-26

A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomyNCT02849990 · 2017-03-09

68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before SurgeryNCT03368547 · 2016-12-12

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionNCT01638533 · 2012-08-03

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney CancerNCT01480154 · 2011-11-23

ACTIVE_NOT_RECRUITING

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerNCT01251861 · 2011-03-17

Common interventions

Leading sponsors

National Cancer Institute (NCI)3 Alliance for Clinical Trials in Oncology1 City of Hope Medical Center1 Jonsson Comprehensive Cancer Center1 University of Utah1 University of Washington1

Trial status mix

COMPLETED5

RECRUITING2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE23

PHASE12

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.